LaserLyte Joins the Armed Citizen Alliance as a Founding Partner
LaserLyte is Committed with ACA in a United Goal of Achieving Readily Available Personal and Home Defense Training and Tools for all American Citizens.
COTTONWOOD, AZ --(Ammoland.com)- LaserLyte, innovators of firearms laser technology has joined the ranks of the industry’s most prestigious companies in becoming a Founding Partner with the Armed Citizen Alliance (ACA).
For 25-years, LaserLyte has been developing and producing firearms laser systems to build firearms skills and confidence for new and seasoned shooters. As the concealed carry market increased, LaserLyte lead the industry in producing some of the smallest and lightest firearms lasers in the world for the smallest and most popular concealed carry pistols. LaserLyte also leads the industry with innovative, interactive laser training target systems for the home or range with the belief that a prepared citizen is a trained citizen.
Armed Citizen Alliance
The ACA is a non-profit corporation founded to provide ordinary citizens an avenue to practice, train and become familiar with the use of concealed carry handguns and other personal defense firearms in an organized, recreational context that simulates real-world situations.
The ACA has two core missions: first, to provide their community and industry with an organization that will act as their “first-contact” point for practice and familiarization, and second, to offer a comfortable and welcoming program to bring new and inexperienced firearms owners in and help them gain confidence and familiarity with their personal and home defense firearm while having fun.
“LaserLyte actively supports our Second Amendment rights and is proud to partner with ACA,” Aaron Moore, VP of Sales and Marketing for LaserLyte commented. “ACA and LaserLyte share a common passion and we look forward to working with them in their commitment to providing information and safe and structured training and recreation opportunities for firearms owners.”
For more information, visit www.laserlyte.com and check us out on Facebook.
About LaserLyte®:
LaserLyte®, the leader in laser technology for over 25 years. Our mission is to heighten the experience of shooting. For additional information about LaserLyte®, visit www.laserlyte.com. Keep up to date with LaserLyte on Facebook or Twitter. Visit the LaserLyte® YouTube page for all the LaserLyte action.
About Armed Citizen Alliance (ACA):
The Armed Citizen Alliance is a not-for-profit corporation chartered in the State of Illinois. That is by deliberate choice, to demonstrate that even in the only state without concealed-carry legislation, American citizens still have the Right to Bear Arms.
The primary institutional purpose of the ACA is to provide a national context for citizen practice and preparedness with concealed carry handguns and other personal defense and home defense firearms, and the production of the annual National Armed Citizen Challenge event (NAC2). It is governed by officers elected by its corporate Board of Directors. An Advisory Council of representatives from the firearms industry, other shooting sports organizations, and law-enforcement officers assists ACA Officers and Directors in making policy. All ACA dues revenues, sponsor contributions, and event proceeds go entirely to ACA administrative costs and ACA program production costs. ACA has no paid employees. All ACA Officers and Directors are volunteers. www.armedcitizenalliance.com
2012-10-03 22:36:04
Source: http://www.ammoland.com/2012/10/03/laserlyte-joins-the-armed-citizen-alliance/
Source:
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
